Cargando…

Turning antibodies off and on again using a covalently tethered blocking peptide

In their natural form, antibodies are always in an “on-state” and are capable of binding to their targets. This leads to undesirable interactions in a wide range of therapeutic, analytical, and synthetic applications. Modulating binding kinetics of antibodies to turn them from an “off-state” to an “...

Descripción completa

Detalles Bibliográficos
Autores principales: Brasino, Michael, Wagnell, Eli, Hamilton, Sean, Ranganathan, Srivathsan, Gomes, Michelle M., Branchaud, Bruce, Messmer, Bradley, Ibsen, Stuart D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741643/
https://www.ncbi.nlm.nih.gov/pubmed/36496512
http://dx.doi.org/10.1038/s42003-022-04094-1
_version_ 1784848370036113408
author Brasino, Michael
Wagnell, Eli
Hamilton, Sean
Ranganathan, Srivathsan
Gomes, Michelle M.
Branchaud, Bruce
Messmer, Bradley
Ibsen, Stuart D.
author_facet Brasino, Michael
Wagnell, Eli
Hamilton, Sean
Ranganathan, Srivathsan
Gomes, Michelle M.
Branchaud, Bruce
Messmer, Bradley
Ibsen, Stuart D.
author_sort Brasino, Michael
collection PubMed
description In their natural form, antibodies are always in an “on-state” and are capable of binding to their targets. This leads to undesirable interactions in a wide range of therapeutic, analytical, and synthetic applications. Modulating binding kinetics of antibodies to turn them from an “off-state” to an “on-state” with temporal and spatial control can address this. Here we demonstrate a method to modulate binding activity of antibodies in a predictable and reproducible way. We designed a blocking construct that uses both covalent and non-covalent interactions with the antibody. The construct consisted of a Protein L protein attached to a flexible linker ending in a blocking-peptide designed to interact with the antibody binding site. A mutant Protein L was developed to enable photo-triggered covalent crosslinking to the antibody at a specific location. The covalent bond anchored the linker and blocking peptide to the antibody light chain keeping the blocking peptide close to the antibody binding site. This effectively put the antibody into an “off-state”. We demonstrate that protease-cleavable and photocleavable moieties in the tether enable controlled antibody activation to the “on-state” for anti-FLAG and cetuximab antibodies. Protein L can bind a range of antibodies used therapeutically and in research for wide applicability.
format Online
Article
Text
id pubmed-9741643
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97416432022-12-12 Turning antibodies off and on again using a covalently tethered blocking peptide Brasino, Michael Wagnell, Eli Hamilton, Sean Ranganathan, Srivathsan Gomes, Michelle M. Branchaud, Bruce Messmer, Bradley Ibsen, Stuart D. Commun Biol Article In their natural form, antibodies are always in an “on-state” and are capable of binding to their targets. This leads to undesirable interactions in a wide range of therapeutic, analytical, and synthetic applications. Modulating binding kinetics of antibodies to turn them from an “off-state” to an “on-state” with temporal and spatial control can address this. Here we demonstrate a method to modulate binding activity of antibodies in a predictable and reproducible way. We designed a blocking construct that uses both covalent and non-covalent interactions with the antibody. The construct consisted of a Protein L protein attached to a flexible linker ending in a blocking-peptide designed to interact with the antibody binding site. A mutant Protein L was developed to enable photo-triggered covalent crosslinking to the antibody at a specific location. The covalent bond anchored the linker and blocking peptide to the antibody light chain keeping the blocking peptide close to the antibody binding site. This effectively put the antibody into an “off-state”. We demonstrate that protease-cleavable and photocleavable moieties in the tether enable controlled antibody activation to the “on-state” for anti-FLAG and cetuximab antibodies. Protein L can bind a range of antibodies used therapeutically and in research for wide applicability. Nature Publishing Group UK 2022-12-10 /pmc/articles/PMC9741643/ /pubmed/36496512 http://dx.doi.org/10.1038/s42003-022-04094-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Brasino, Michael
Wagnell, Eli
Hamilton, Sean
Ranganathan, Srivathsan
Gomes, Michelle M.
Branchaud, Bruce
Messmer, Bradley
Ibsen, Stuart D.
Turning antibodies off and on again using a covalently tethered blocking peptide
title Turning antibodies off and on again using a covalently tethered blocking peptide
title_full Turning antibodies off and on again using a covalently tethered blocking peptide
title_fullStr Turning antibodies off and on again using a covalently tethered blocking peptide
title_full_unstemmed Turning antibodies off and on again using a covalently tethered blocking peptide
title_short Turning antibodies off and on again using a covalently tethered blocking peptide
title_sort turning antibodies off and on again using a covalently tethered blocking peptide
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741643/
https://www.ncbi.nlm.nih.gov/pubmed/36496512
http://dx.doi.org/10.1038/s42003-022-04094-1
work_keys_str_mv AT brasinomichael turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide
AT wagnelleli turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide
AT hamiltonsean turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide
AT ranganathansrivathsan turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide
AT gomesmichellem turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide
AT branchaudbruce turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide
AT messmerbradley turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide
AT ibsenstuartd turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide